Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233–54.

Article  PubMed  Google Scholar 

Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet Lond Engl. 2014;383(9927):1490–502.

Article  Google Scholar 

De Sousa E, Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell. 2011;9(5):476–85.

Article  Google Scholar 

Giovannetti E, Backus HHJ, Wouters D, Ferreira CG, van Houten VMM, Brakenhoff RH, et al. Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels. Br J Cancer. 2007;96(5):769–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vunjak M, Versteeg GA. TRIM proteins. Curr Biol CB. 2019;29(2):R42-4.

Article  CAS  PubMed  Google Scholar 

Hatakeyama S. TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis. Trends Biochem Sci. 2017;42(4):297–311.

Article  CAS  PubMed  Google Scholar 

Mohammadi A, Pour Abbasi MS, Khorrami S, Khodamoradi S, Mohammadi Goldar Z, Ebrahimzadeh F. The TRIM proteins in cancer: from expression to emerging regulatory mechanisms. Clin Transl Oncol. 2022;24(3):460–70.

Article  CAS  PubMed  Google Scholar 

Marzano F, Caratozzolo MF, Pesole G, Sbisà E, Tullo A. TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance. Biomedicines. 2021;9(3):241.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu K, Pan Y, Huang Z, Liang H, Ding ZY, Zhang B. TRIM proteins in hepatocellular carcinoma. J Biomed Sci. 2022;29(1):69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhan W, Zhang S. TRIM proteins in lung cancer: Mechanisms, biomarkers and therapeutic targets. Life Sci. 2021;1(268): 118985.

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372): n71.

Article  Google Scholar 

Wells G, Shea B, O'Connell J. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Health Research Institute Web site. 2014;7(1).

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fitzgerald S, Sheehan KM, O’Grady A, Kenny D, O’Kennedy R, Kay EW, et al. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients: TRIM28 predicts survival in colorectal cancer. J Gastroenterol Hepatol. 2013;28(6):967–74.

Article  CAS  PubMed  Google Scholar 

Xu W, Xu B, Yao Y, Yu X, Cao H, Zhang J, et al. RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells. Oncol Rep. 2016;36(3):1411–8.

Article  CAS  PubMed  Google Scholar 

Ma SZ, et al. Expression of TRIM28 in colorectal cancer tissues and its effect on the proliferation and migration of cancer cells. Shandong Medical Journal. 2017;57:28–30.

Google Scholar 

Fengqin Wang. Prognostic relevance of tripartite motif containing 24 expression in colorectal cancer. Pathol - Res Pract. 2017;213(10):1271–5.

Article  Google Scholar 

Haiyu Wang Lu, Yao Yuda Gong, Zhang Bo. TRIM31 regulates chronic inflammation via NF-κB signal pathway to promote invasion and metastasis in colorectal cancer. Am J Transl Res. 2018;10(4):1247.

PubMed  PubMed Central  Google Scholar 

Zhang Y, Feng Y, Ji D, Wang Q, Qian W, Wang S, et al. TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer. Int J Oncol. 2018;53(2):620–32.

CAS  PubMed  PubMed Central  Google Scholar 

Chen Daici, Li Yichen, Zhang Xiaowen, Haiyong Wu, Wang Qian, Cai Jian, et al. Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation. Oncogene. 2019;38(37):6429–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li CG, Hu H, Yang XJ, Huang CQ, Yu XQ. TRIM44 Promotes Colorectal Cancer Proliferation, Migration, and Invasion Through the Akt/mTOR Signaling Pathway. OncoTargets Ther. 2019;12:10693–701.

Article  CAS  Google Scholar 

Liang Q, Tang C, Tang M, Zhang Q, Gao Y, Ge Z. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4. J Exp Clin Cancer Res CR. 2019;12(38):159.

Article  Google Scholar 

Ding Y, et al. expression of TRIM14 in Colorectal Cancer and Its Clinical Significance. Acta Med Univ Sci Technol Huazhong. 2020;49(3):323–7.

Google Scholar 

Zheng Shuier, Zhou Chenliang, Wang Yonggang, Li Hongtao, Sun Yong, Shen Zan. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1. J Exp Clin Cancer Res CR. 2020;28(39):23.

Article  Google Scholar 

Han Y, Tan Y, Zhao Y, Zhang Y, He X, Yu L, et al. TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer. J Cell Mol Med. 2020;24(10):5491–500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu J, Chen J, Xiang S, Zhou X, Li J. Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape. J Adv Res. 2023;S2090–1232(23):00024–3.

Google Scholar 

Yang X, Zhang Y, Xue Z, Hu Y, Zhou W, Xue Z, et al. TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein. J Exp Clin Cancer Res CR. 2022;41(1):336.

Article  CAS  PubMed  Google Scholar 

Ji J, Ding K, Luo T, Zhang X, Chen A, Zhang D, et al. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα. Cell Death Differ. 2021;28(1):367–81.

Article  CAS  PubMed  Google Scholar 

Liu Y, Tao S, Liao L, Li Y, Li H, Li Z, et al. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nat Commun. 2020;11(1):348.

Article  PubMed  PubMed Central  Google Scholar 

Guo Y, Zhou Y, Gu X, Xiang J. Tripartite motif 52 (TRIM52) promotes proliferation, migration, and regulation of colon cancer cells associated with the NF-κB signaling pathway. J Gastrointest Oncol. 2022;13(3):1097–111.

Article  PubMed  PubMed Central  Google Scholar 

Dahpy MA, Salama RHM, Kamal AA, El-Deek HE, Abdel Motaleb AA, Abd-El-Rehim AS, et al. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer. J Biochem Mol Toxicol. 2022;36(7):e23065.

Article  CAS  PubMed  Google Scholar 

Hu F, Liu Y, Wang F, Fu X, Liu X, Zou Z, et al. Prognostic and clinicopathological significance of TRIM21 in various cancers: A meta and bioinformatic analysis. Medicine (Baltimore). 2023;102(23): e34012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao G, Yang Q, Bao Z, Mao H, Zhang Y, Lin S. Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis. BMC Cancer. 2020;20(1):525.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue Y, Ge W, Shi W, Huang W, Wang R. Prognostic role of tripartite motif containing 24 in various human solid malignant neoplasms: An updated meta-analysis and systematic review. Medicine (Baltimore). 2021;100(51): e28383.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He Y, Peng KW, Tang T, Deng L, Ye ZL, Luo MJ, et al. Prognostic Implications of Tripartite Motif Containing 24 Expression Levels in Patients with Solid Tumors: A Systematic Review and Meta-Analysis. Genet Test Mol Biomark. 2019;23(7):473–9.

Article  Google Scholar